Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
They will not be able to do a RS, with everything going on now, would not be approved, plus the board would need to meet and approve it and they have not.
Pfizer killed 11 kids and no one when to jail.........Pfizer Case Over Test That Killed 11 Kids Could Blow the Lid Off Foreign Drug Trials
FDA approved.
Drug giant Merck accused of deaths cover-up
By Jim Giles
It is perhaps the biggest drug scandal of recent years. Before Merck withdrew Vioxx in 2004, the popular painkiller was linked to heart attacks in tens of thousands of people. Now researchers have alleged that Merck knew of the dangers years earlier, but tweaked statistics and hid data so that regulators remained in the dark.
Vioxx was a blockbuster drug for Merck in the 5 years it was on the market, generating billions of dollars in revenue. After it was linked to heart attacks and strokes, the firm pulled its product, and earlier this year Merck agreed to provide almost US$5 billion in compensation to those claiming to have been harmed.
Deadly Medicine
Prescription drugs kill some 200,000 Americans every year. Will that number go up, now that most clinical trials are conducted overseas—on sick Russians, homeless Poles, and slum-dwelling Chinese—in places where regulation is virtually nonexistent, the F.D.A. doesn’t reach, and “mistakes” can end up in pauper’s graves? The authors investigate the globalization of the pharmaceutical industry, and the U.S. Government’s failure to rein in a lethal profit machine
Pfizer won their case and they killed 11 kids.
Pfizer Case Over Test That Killed 11 Kids Could Blow the Lid Off Foreign Drug Trials
JUN 30, 2010 5:58 PM EDT MARKETS
BY JIM EDWARDS / MONEYWATCH
?The U.S. Supreme Court's decision to send the Pfizer (PFE) Trovan case to trial threatens to do the one thing the pharmaceutical industry most wishes won't happen: Reveal to Americans exactly how foreign drug trials are unregulated, sometimes dangerous and often unreliable.
The seemingly endless Trovan case involves Pfizer's test of a meningitis drug on 200 childrenin Kano, Nigeria, in 1996. Pfizer failed to get proper consent for the trial. Eleven kids died and the drug was eventually nixed because it was too dangerous. The events may have inspired the book and film, The Constant Gardener. Pfizer has attempted to do the right thing in recent years by settling the case for $75 million, but it's been stymied by local bureaucracy and corruption.
1000% for me. Good luck to us all
Not yet, but soon .0008
Np good luck too you too. But you and I both know EQLB is and always will be a joke, see you after the RS which is next, same as all 1billion OS otc do....Mo needs the money for another pool party. Yes
Read the post your not the only ones replying. Haha
You guy are fun to f...with thanks for the laugh. Ta. Ta
It's down 50%
In two day and your still up 1000% same as two days ago . Is that new math..
Again just a pump, no product, on back order, need to sell stock to buy product they will not sell him unless he orders 200k of can and he has no money so pump so he can buy and support is life. That is a scam. Are you paid to pump this position...yes you are. Ta ta
I am to make statement that tell other to beware of pumper and the scam that is eqlb. The product is good but it's liquid health labs not eqlb they are a joke.. or better put mojoke
Point is your a pumper and a BSer. Ta ta
Still up 1000% I think not.. ta ta
Not any more tata
Did everyone forget about Timbo, are you saying he didn't help? Multi millionaire... is that pump died?, Also BJ pen, why no word on another big order, 200k of cans two years ago?? What's the date code on that drink?
The good new is they can not do a RS, the bad news is it's because they are non reporting, if they report, then they will also report the RS because like all otc that are at a billion share they RS. Good luck
You guys must have ordered from somewhere else there's no way possible that Kevin Harrington is invested in a company that can't ship product especially when they don't make it they just buy it right GM
https://i2.wp.com/www.drinklastshot.com/wp-content/uploads/2018/02/6pk_cans_white.jpg?fit=948%2C1398
Here is a link to buy on line, you can buy from any state, is that not National???? Again clueless
Clueless, it be out for yearssssssss, do some DD
Shark Tank’ Failures: 10 Products That Didn’t Make It
Google this and see how many failures Kevin had
No GM I don't believe he would sign up for this for a couple reasons one it's a pink sheet stock that hasn't filed financials in a long time to they haven't bought any stock in a couple years and they only bought 200000 cans of which their website tells that they only sold a hundred thousand I think this s*** is outdated
three is they don't own a product they only own a distribution right and you can buy it through liquid Health Labs Direct so no why would he sign up for this
That's where you're wrong whenever it starts moving an unusual volume with pumping I get in but I'm happy to take a 25 to 30% gain and get the hell out before the dump happens I have no problem with making money on these scams but I won't pump it
EQ Labs Announces Distribution Agreement for Last Shot® Beverages
October 21, 2014 01:13 PM Eastern Daylight Time
LAS VEGAS--(BUSINESS WIRE)--EQ Labs, Inc. (“EQ.” or “the Company”) (OTC.BB: EQLB), announced today that it has entered into a distribution agreements with Liquid Health, Inc. to distribute Last Shot® in the United States.
“The agreement with EQ Labs gives us the distribution and marketing we have been seeking in the United States”
Tweet this
“We are excited to announce the launch of Last Shot®, the 3 in 1 can beverage (Cranberry flavor) that helps Detox, Energize and Hydrate the consumer's body,” states Mo Owens, CEO of EQ. “This product will be available to the retail customers, major night clubs, hotels and resorts this fall and will further enhance our products available to the consumer.” EQ will begin distribution and marketing in Las Vegas. CEO Mo Owens stated, “What better stage to market our new beverage…just turn the light on!”
In addition to marketing the new look and formulations of the Last Shot cans, the product will be available in the innovative PowerCap™ delivery system. The PowerCap™ allows consumers to conveniently take Last Shot® On-the-Go during the day or night with any bottle of water or beverage.
“The agreement with EQ Labs gives us the distribution and marketing we have been seeking in the United States,” states Derek Hopkins, President of Liquid Health, Inc. “We feel the duration required to reach this agreement has provided a clear alignment between our two companies and focused direction for the Last Shot® brand,” Hopkins adds.
About EQ Lab, Inc.:
EQ Energy Drink, Inc. is the owner of EQ and various consumer products related to the health and wellness.
About Liquid Health, Inc.:
Liquid Health Labs, Inc is a leading innovation and development company of dosing cap technology and mixing solutions for the nutraceutical, OTC/pharmaceutical, beverage, and consumer goods markets. The core technology is branded as Boosted by Power Cap™, and Liquid Health Labs has developed unique products including Last Shot®, Nutrelle® - Beauty from Within and Fresh Healthy Stuff…in the Cap. www.mypowercap.com.
Safe Harbor:
This news release contains “forward-looking statements” as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. These forward-looking statements generally can be identified by phrases such as EQ Energy Drink, Inc.. or its management “believes,” “expects,” “anticipates,” “foresees,” “forecasts,” “estimates” or other words or phrases of similar import. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new business opportunities and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
Contact Information:
EQ ENERGY DRINK, Inc
Maurice Owens, President and CEO
Phone: (702) 806-5943
Web: www.Drinkeq.com
Email: mo@drinkeq.com
Twitter: eqceo
Contacts
EQ ENERGY DRINK, Inc
Maurice Owens, 702-806-5943
President and CEO
mo@drinkeq.com
EQ LABS, INC.
OTCBB:EQLB ? ?
Log InSign Up
More from Business Wire
BlogAppsUK/IrelandDeutschlandFranceHong KongItalyJapanEON: Enhanced Online NewsTradeshownews.com
Contact UsUK Tax StrategyPrivacy StatementTerms of Use© 2018 Business Wire, Inc.
that was not a dump that was my buy going through. Thank you very much.
May it has something to do with revenue increases by 2mil and cost/ admin increases by 4mil, total loss now 8mil a quarter.
That's a share increase, payment to a partner, and for a division losing them money, all good news......not.
Only one, totally agree...
EQLB to offer new last shot crypto coin, sign up now, Mo money
Yes you will, unless you only have 10k of shares and.you can sell anytime for 9 bucks.
That's one way to look at it, but in reality 78k for the year with pool parties, hundreds of bar selling, and timbo big backer push the product, Walmart, Costco....etc...that real sucks...Pool Mo can even make a wage from that, good thing golfing and pool parties are a write off.
VNDM selling now, triple zeros coming, maybe it's Mo trying to get some money to bring financials current
For more details, contact us on 08032193500, 08033288087.
Email: lastshotng@gmail.com
Instagram:@lastshotnigeria facebook:@lastshotng twitter: lastshotnigeria
Where are EQ financials oh wait wait for it wait wait for it oh they have none either that was a stupid reply.
No EQ should turn it over to the Nigerian group they're having a lot more success besides you're only able to distribute in Vegas
Hopefully I can get some .0001 this week before the big news.
Thanks, was out of town for a few days, just now about to check the market, you have a great weekend too.
here is some information for you To, hope it helps
OTC Pink® Basic Disclosure Guidelines
Federal securities laws, such as Rules 10b-5 and 15c2-11 of the Securities Exchange Act of 1934 (“Exchange Act”) as well as Rule 144 of the Securities Act of 1933 (“Securities Act”), and state Blue Sky laws, require issuers to provide adequate current information to the public markets. With a view to encouraging compliance with these laws, OTC Markets Group has created these OTC Pink Basic Disclosure Guidelines. We use the basic disclosure information provided by OTC Pink companies under these guidelines to designate the appropriate tier in the OTC Pink marketplace: Current, Limited or No Information. OTC Markets Group may require companies with securities designated as Caveat Emptor to make additional disclosures in order to qualify for OTC Pink Current Information tier.
Qualifications for the OTC Pink - Current Information Tier
Companies that make the information described below publicly available on a timely basis (90 days after fiscal year end for Annual Reports; 45 days after each fiscal quarter end for Quarterly Reports) qualify for the Current Information Tier. Financial reports must be prepared according to U.S. GAAP or IFRS, but are not required to be audited to qualify for the OTC Pink Current Information tier.
Initial Qualification:
1. Subscribe to the OTC Disclosure & News Service on www.OTCIQ.com to publish your financial reports and material news.
2. Create the following documents, save them in PDF format and upload them via www.OTCIQ.com:
• Annual Financial statements (Document must Include: Balance Sheet, Income Statement, Statement of Cash Flows, Notes to Financial Statements) for the previous two fiscal years. If these reports are audited, please attach the audit letter from the PCAOB registered audit firm. Each year’s Annual Financial statements should be posted separately under the report type “Annual Report” in OTCIQ.
• Any subsequent Quarterly Reports since the most recent Annual Report.
• The most recent fiscal period end report should also include information in accordance with these OTC Pink Basic Disclosure Guidelines; use the fillable form beginning on page 3.
3. If financial reports are not audited by a PCAOB registered audit firm:
• Submit a signed Attorney Letter Agreement (first two pages of the Attorney Letter Guidelines).
• After following the appropriate procedures with a qualified attorney, upload an Attorney Letter complying with Attorney Letter Guidelines through your otciq.com account.
Ongoing Qualification:
1. For each Fiscal Quarter End, upload a Quarterly Report via www.OTCIQ.com within 45 days of the quarter end. (A separate quarterly report is not required for the 4th quarter.) The Quarterly Report should include:
? Information in accordance with these OTC Pink Basic Disclosure Guidelines -- use the fillable form beginning on page 3.
? Quarterly financial statements (Balance Sheet, Income Statement, Statement of Cash Flows, Notes to Financial Statements).
? No Audit Letter or Attorney Letter is required.
2. For each Fiscal Year End, upload an Annual Report within 90 days of the fiscal year end. The Annual Report should include:
? Information in accordance with these OTC Pink Basic Disclosure Guidelines -- use the fillable form beginning on page 3.
? Annual financial statements (Balance Sheet, Income Statement, Statement of Cash Flows, Notes to Financial Statements, and Audit Letter, if the financial statements are audited).
3. If financial reports are not audited by a PCAOB registered audit firm, upload an Attorney Letter via www.OTCIQ.com complying with the Attorney Letter Guidelines within 120 days of the fiscal year end.
Qualifications for the OTC Pink - Limited Information Tier
Companies that make the information described below publicly available within the prior 6 months qualify for the Limited Information Tier.
1. Subscribe to the OTC Disclosure & News Service on www.OTCIQ.com to publish your financial reports and material news.
2. Create a Quarterly Report or Annual Report for a fiscal period ended within the previous 6 months, save it in PDF format and upload it via www.OTCIQ.com. The Quarterly Report or Annual Report includes:
? Balance Sheet, Income Statement, and Total Number of Issued and Outstanding Shares. Financial statements must be prepared in accordance with US GAAP, but are not required to be audited. (Please note that Cash Flow Statements are not required to qualify for the Limited Information tier; however, unless the financial statements include a Cash Flow Statement, no financial data will be included in the OTC Financials Data Service, which distributes company financial data to online investor portals and makes the data available on your company’s Financials tab on www.otcmarkets.com)
? A company in the Limited Information tier, may, but is not required to, include information in accordance with these OTC Pink Basic Disclosure Guidelines using the fillable form beginning on page 3.
Current Reporting of Material Corporate Events
OTC Markets Group encourages companies to make public disclosure available regarding corporate events that may be material to the issuer and its securities. Persons with knowledge of such events would be considered to be in possession of material nonpublic information and may not buy or sell the issuer’s securities until or unless such information is made public. If not included in the issuer’s previous public disclosure documents or if any of the following events occur after the publication of such disclosure documents, the issuer shall publicly disclose such events by disseminating a news release within 4 business days following their occurrence, and posting such news release through the OTC Disclosure & News Service.
Material corporate events include:
• Entry or Termination of a Material Definitive Agreement
• Completion of Acquisition or Disposition of Assets, Including but not Limited to mergers
• Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of an Issuer
• Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
• Costs Associated with Exit or Disposal Activities
• Material Impairments
• Sales of Equity Securities
• Material Modification to Rights of Security Holders
• Changes in Issuer's Certifying Accountant
• Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
• Changes in Control of Issuer
• Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
• Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
• Amendments to the Issuer's Code of Ethics, or Waiver of a Provision of the Code of Ethics
• Other events the issuer considers to be of importance
OTC Pink Basic Disclosure Guidelines
1) Name of the issuer and its predecessors (if any)
In answering this item, please also provide any names used by predecessor entities in the past five years and the dates of the name changes.
2) Address of the issuer’s principal executive offices
Company Headquarters
Address 1:
Address 2:
Address 3:
Phone:
Email:
Website(s):
IR Contact
Address 1:
Address 2:
Address 3:
Phone:
Email:
Website(s):
3) Security Information
Trading Symbol:
Exact title and class of securities outstanding:
CUSIP:
Par or Stated Value:
Total shares authorized: as of:
Total shares outstanding: as of:
Additional class of securities (if necessary):
Trading Symbol:
Exact title and class of securities outstanding:
CUSIP:
Par or Stated Value:
Total shares authorized: as of:
Total shares outstanding: as of:
Transfer Agent
Name:
Address 1:
Address 2:
Address 3:
Phone:
Is the Transfer Agent registered under the Exchange Act?* Yes: 0 No: 0
*To be included in the OTC Pink Current Information tier, the transfer agent must be registered under the Exchange Act.
List any restrictions on the transfer of security:
Describe any trading suspension orders issued by the SEC in the past 12 months.
List any stock split, stock dividend, recapitalization, merger, acquisition, spin-off, or reorganization either currently anticipated or that occurred within the past 12 months:
4) Issuance History
List below any events, in chronological order, that resulted in changes in total shares outstanding by the issuer in the past two fiscal years and any interim period. The list shall include all offerings of equity securities, including debt convertible into equity securities, whether private or public, and all shares or any other securities or options to acquire such securities issued for services, describing (1) the securities, (2) the persons or entities to whom such securities were issued and (3) the services provided by such persons or entities. The list shall indicate:
A. The nature of each offering (e.g., Securities Act Rule 504, intrastate, etc.);
B. Any jurisdictions where the offering was registered or qualified;
C. The number of shares offered;
D. The number of shares sold;
E. The price at which the shares were offered, and the amount actually paid to the issuer;
F. The trading status of the shares; and
G. Whether the certificates or other documents that evidence the shares contain a legend (1) stating that the shares have not been registered under the Securities Act and (2) setting forth or referring to the restrictions on transferability and sale of the shares under the Securities Act.
5) Financial Statements
Provide the financial statements described below for the most recent fiscal year end or quarter end to maintain qualification for the OTC Pink Current Information tier. For the initial disclosure statement (qualifying for Current Information for the first time) please provide reports for the two previous fiscal years and any interim periods.
A. Balance sheet;
B. Statement of income;
C. Statement of cash flows;
D. Financial notes; and
E. Audit letter, if audited
The financial statements requested pursuant to this item shall be prepared in accordance with US GAAP by persons with sufficient financial skills.
You may either (i) attach/append the financial statements to this disclosure statement or (ii) post such financial statements through the OTC Disclosure & News Service as a separate report using the appropriate report name for the applicable period end. (“Annual Report,” “Quarterly Report” or “Interim Report”).
If you choose to publish the financial reports separately as described in part (ii) above, you must state in the accompanying disclosure statement that such financial statements are incorporated by reference. You may reference the document(s) containing the required financial statements by indicating the document name, period end date, and the date that it was posted to otciq.com in the field below.
Information contained in a Financial Report is considered current until the due date for the subsequent Financial Report. To remain in the OTC Pink Current Information tier, a company must post its Annual Report within 90 days from its fiscal year-end date and Quarterly Reports within 45 days of its fiscal quarter-end date.
6) Describe the Issuer’s Business, Products and Services
Describe the issuer’s business so a potential investor can clearly understand the company. In answering this item, please include the following:
A. a description of the issuer’s business operations;
B. Date and State (or Jurisdiction) of Incorporation:
C. the issuer’s primary and secondary SIC Codes;
D. the issuer’s fiscal year end date;
E. principal products or services, and their markets;
7) Describe the Issuer’s Facilities
The goal of this section is to provide a potential investor with a clear understanding of all assets, properties or facilities owned, used or leased by the issuer.
In responding to this item, please clearly describe the assets, properties or facilities of the issuer, give the location of the principal plants and other property of the issuer and describe the condition of the properties. If the issuer does not have complete ownership or control of the property (for example, if others also own the property or if there is a mortgage on the property), describe the limitations on the ownership.
If the issuer leases any assets, properties or facilities, clearly describe them as above and the terms of their leases.
8) Officers, Directors, and Control Persons
The goal of this section is to provide an investor with a clear understanding of the identity of all the persons or entities that are involved in managing, controlling or advising the operations, business development and disclosure of the issuer, as well as the identity of any significant shareholders.
A. Names of Officers, Directors, and Control Persons. In responding to this item, please provide the names of each of the issuer’s executive officers, directors, general partners and control persons (control persons are beneficial owners of more than five percent (5%) of any class of the issuer’s equity securities), as of the date of this information statement.
B. Legal/Disciplinary History. Please identify whether any of the foregoing persons have, in the last five years, been the subject of:
1. A conviction in a criminal proceeding or named as a defendant in a pending criminal proceeding (excluding traffic violations and other minor offenses);
2. The entry of an order, judgment, or decree, not subsequently reversed, suspended or vacated, by a court of competent jurisdiction that permanently or temporarily enjoined, barred, suspended or otherwise limited such person’s involvement in any type of business, securities, commodities, or banking activities;
3. A finding or judgment by a court of competent jurisdiction (in a civil action), the Securities and Exchange Commission, the Commodity Futures Trading Commission, or a state securities regulator of a violation of federal or state securities or commodities law, which finding or judgment has not been reversed, suspended, or vacated; or
4. The entry of an order by a self-regulatory organization that permanently or temporarily barred suspended or otherwise limited such person’s involvement in any type of business or securities activities.
C. Beneficial Shareholders. Provide a list of the name, address and shareholdings or the percentage of shares owned by all persons beneficially owning more than ten percent (10%) of any class of the issuer’s equity securities. If any of the beneficial shareholders are corporate shareholders, provide the name and address of the person(s) owning or controlling such corporate shareholders and the resident agents of the corporate shareholders.
9) Third Party Providers
Please provide the name, address, telephone number, and email address of each of the following outside providers that advise your company on matters relating to operations, business development and disclosure:
Legal Counsel
Name:
Firm:
Address 1:
Address 2:
Phone:
Email:
Accountant or Auditor
Name:
Firm:
Address 1:
Address 2:
Phone:
Email:
Investor Relations Consultant
Name:
Firm:
Address 1:
Address 2:
Phone:
Email:
Other Advisor: Any other advisor(s) that assisted, advised, prepared or provided information with respect to this disclosure statement.
Name:
Firm:
Address 1:
Address 2:
Phone:
Email:
10) Issuer Certification
The issuer shall include certifications by the chief executive officer and chief financial officer of the issuer (or any other persons with different titles, but having the same responsibilities).
The certifications shall follow the format below:
I, [identify the certifying individual] certify that:
1. I have reviewed this [specify either annual or quarterly disclosure statement] of [identify issuer];
2. Based on my knowledge, this disclosure statement does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this disclosure statement; and
3. Based on my knowledge, the financial statements, and other financial information included or incorporated by reference in this disclosure statement, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this disclosure statement.
[Date]
[CEO’s Signature]
[CFO’s Signature]
(Digital Signatures should appear as “/s/ [OFFICER NAME]”)
[Title]